| Schedule of the details of the revision |
| | | | | | | | | | | | For The Three Months Ended March 31, 2026 | | | As Originally Reported | | Adjustment | | As Revised | Condensed Consolidated Statements of Operations: | | | | | | | | | | Revenue | | $ | 4,846,430 | | $ | (900,000) | | $ | 3,946,430 | Gross profit | | $ | 1,417,292 | | $ | (900,000) | | $ | 517,292 | Net loss | | $ | (28,119,844) | | $ | (900,000) | | $ | (29,019,844) | Net loss per share, basic and diluted | | $ | (0.61) | | $ | (0.02) | | $ | (0.63) |
| | | | | | | | | | | | As of March 31, 2026 | Condensed Consolidated Balance Sheets: | | | | | | | | | | Grant receivable | | $ | 3,254,612 | | $ | (900,000) | | $ | 2,354,612 | Total current assets | | $ | 16,806,075 | | $ | (900,000) | | $ | 15,906,075 | Total assets | | $ | 105,508,841 | | $ | (900,000) | | $ | 104,608,841 | Total stockholders’ equity | | $ | 94,575,834 | | $ | (900,000) | | $ | 93,675,834 |
|